SCD treatment substantially decreased all measured plasma levels of cytokines: IL-6, MCP-1, IL-8, IL-10 and tumor necrosis factor (TNF)-a after only two days of SCD treatment compared to baseline values. The gene discussed is CCL2; the disease is Schnyder corneal dystrophy.